Viveve Medical, Inc.
VIVE
$0.0002
$0.000.00%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 1.68M | 1.80M | 1.64M | 1.71M | 1.62M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.68M | 1.80M | 1.64M | 1.71M | 1.62M |
| Cost of Revenue | 1.14M | 1.50M | 1.32M | 1.75M | 1.50M |
| Gross Profit | 546.00K | 294.00K | 320.00K | -41.00K | 114.00K |
| SG&A Expenses | 3.41M | 3.39M | 3.65M | 3.37M | 2.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.35M | 6.82M | 7.11M | 7.69M | 7.11M |
| Operating Income | -4.66M | -5.02M | -5.47M | -5.99M | -5.49M |
| Income Before Tax | -4.98M | -5.80M | -5.89M | -6.26M | -5.86M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.98M | -5.80M | -5.89M | -6.26M | -5.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -68.00K | -- |
| Net Income | -4.98M | -5.80M | -5.89M | -6.33M | -5.86M |
| EBIT | -4.66M | -5.02M | -5.47M | -5.99M | -5.49M |
| EBITDA | -4.49M | -4.83M | -5.27M | -5.75M | -5.24M |
| EPS Basic | -0.59 | -0.67 | -0.67 | -0.71 | -0.67 |
| Normalized Basic EPS | -0.29 | -0.31 | -0.35 | -0.38 | -0.35 |
| EPS Diluted | -0.59 | -0.67 | -0.67 | -0.71 | -0.67 |
| Normalized Diluted EPS | -0.29 | -0.31 | -0.35 | -0.38 | -0.35 |
| Average Basic Shares Outstanding | 10.67M | 10.64M | 10.62M | 10.61M | 10.59M |
| Average Diluted Shares Outstanding | 10.67M | 10.64M | 10.62M | 10.61M | 10.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
